Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent “Late” Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study

REFERENCES

1. 1.↵
   1. Cutolo M,
   2. Sulli A,
   3. Smith V

   . Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010;6:578–87.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Cutolo M,
   2. Herrick AL,
   3. Distler O,
   4. Becker MO,
   5. Beltran E,
   6. Carpentier P,
   7. et al;
   8. CAP Study Investigators

   . Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study. Arthritis Rheumatol 2016;68:2527–39.

   OpenUrl
3. 3.↵
   1. Trombetta AC,
   2. Pizzorni C,
   3. Ruaro B,
   4. Paolino S,
   5. Sulli A,
   6. Smith V,
   7. et al.

   Effects of longterm treatment with bosentan and iloprost on nailfold absolute capillary number, fingertip blood perfusion, and clinical status in systemic sclerosis. J Rheumatol 2016;43:2033–41.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Sulli A,
   2. Pizzorni C,
   3. Smith V,
   4. Zampogna G,
   5. Ravera F,
   6. Cutolo M

   . Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum 2012;64:821–5.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Smith V,
   2. Decuman S,
   3. Sulli A,
   4. Bonroy C,
   5. Piettte Y,
   6. Deschepper E,
   7. et al.

   Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis 2012;71:1636–9.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Van den Hoogen F,
   2. Khanna D,
   3. Fransen J,
   4. Johnson SR,
   5. Baron M,
   6. Tyndall A,
   7. et al.

   2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737–47.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Reed J,
   2. Pope J

   . A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines. Clin Exp Rheumatol 2015;33 Suppl 91:S40–6.

   OpenUrl
8. 8.↵
   1. LeRoy EC,
   2. Black C,
   3. Fleischmajer R,
   4. Jablonska S,
   5. Krieg T,
   6. Medsger TA Jr,
   7. et al.

   Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.

   OpenUrlPubMed
9. 9.↵
   1. Sulli A,
   2. Secchi ME,
   3. Pizzorni C,
   4. Cutolo M

   . Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008;67:885–7.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Cutolo M,
    2. Sulli A,
    3. Pizzorni C,
    4. Accardo S

    . Nailfold videocapillaroscopy of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155–60.

    OpenUrlPubMed